Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease

Liver International

Volumn 35, Issue 11, 2015, Pages 2392-2400

  Shen, Feng ^a   Zheng, Rui Dan ^b   Shi, Jun Ping ^c   Mi, Yu Qiang ^d   Chen, Guo Feng ^e   Hu, Xiqi ^f   Liu, Yong Gang ^d   Wang, Xiao Ying ^a   Pan, Qin ^a   Chen, Guang Yu ^a   Chen, Jian Neng ^b   Xu, Liang ^d   Zhang, Rui Nan ^a   Xu, Lei Ming ^a   Fan, Jian Gao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Department of Hepatology   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^d TIANJIN SECOND PEOPLE S HOSPITAL   (China)

^e 302 MILITARY HOSPITAL   (China)

^f FUDAN UNIVERSITY   (China)

Author keywords

Controlled attenuation parameter; Liver stiffness; Non alcoholic fatty liver disease; Skin capsular distance; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONIC HEPATITIS B; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED ATTENUATION PARAMETER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; ELASTOGRAPH; ELASTOGRAPHY; FATTY LIVER; FEMALE; HEPATOBILIARY PARAMETERS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RIGIDITY; SKIN CAPSULAR DISTANCE; SUBCUTANEOUS FAT; YOUDEN INDEX; BIOPSY; BODY MASS; CHINA; CLINICAL TRIAL; HEPATITIS B; LIVER; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SKIN;

ADULT; AREA UNDER CURVE; BIOPSY; BODY MASS INDEX; CHINA; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 84945435747     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12809     Document Type: Article

References (27)

1. Degos F, Perez P, Roche B, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 2010; 53: 1013-21.
2. Wong GL, Wong VW, Chim AM, et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 2011; 26: 300-5.
3. Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012; 55: 199-208.
4. de Ledinghen V, Vergniol J, Foucher J, et al. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int 2010; 30: 1043-8.
5. Myers RP, Pollett A, Kirsch R, et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 2012; 32: 902-10.
6. de Ledinghen V, Vergniol J, Capdepont M, et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol 2014; 60: 1026-31.
7. Sasso M, Tengher-Barna I, Ziol M, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C. J Viral Hepat 2012; 19: 244-53.
8. Chon YE, Jung KS, Kim SU, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 2013; 34: 102-9.
9. Audiere S, Charbit M, Angelini ED, Oudry J, Sandrin L. Measurement of the skin-liver capsule distance on ultrasound RF data for 1D transient elastography. Med Image Comput Comput Assist Interv 2010; 13: 34-41.
10. Cournane S, Browne JE, Fagan AJ. The effects of fatty deposits on the accuracy of the Fibroscan(R) liver transient elastography ultrasound system. Phys Med Biol 2012; 57: 3901-14.
11. Wong VW, Vergniol J, Wong GL, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012; 107: 1862-71.
12. Fan JG, Jia JD, Li YM, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166). J Dig Dis 2011; 12: 38-44.
13. Shi JP, Fan JG, Wu R, et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2008; 23: 1419-25.
14. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
15. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-93.
16. Kumar M, Rastogi A, Singh T, et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does aetiology affect performance. J Gastroenterol Hepatol 2013; 28: 1194-201.
17. Vigano M, Massironi S, Lampertico P, et al. Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B. Eur J Gastroenterol Hepatol 2010; 22: 180-4.
18. Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-10.
19. Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008; 48: 1718-23.
20. Karlas T, Petroff D, Garnov N, et al. Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS ONE 2014; 9: e91987.
21. Shen F, Zheng RD, Mi YQ, et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol 2014; 20: 4702-11.
22. Jung KS, Kim BK, Kim SU, et al. Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease. PLoS ONE 2014; 9: e98689.
23. Chan WK, Nik MNR, Mahadeva S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2014; 29: 1470-6.
24. Verveer C, Zondervan PE, ten Kate FJ, et al. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int 2012; 32: 622-8.
25. Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.
26. Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-62.
27. Dasarathy S, Dasarathy J, Khiyami A, et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009; 51: 1061-7.